Trials / Terminated
TerminatedNCT00740961
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
The Vulnerable Elders Survey Study of Older Cancer Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- Case Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Learning about changes over time in older patients' ability to function after receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying older patients with newly diagnosed breast cancer or colon cancer.
Detailed description
OBJECTIVES: * Determine the correlation between the Vulnerable Elders Survey (VES-13) and the battery of Comprehensive Geriatric Assessment tools among breast and colon cancer patients, 65 years and older, in an outpatient setting. * Assess and compare the abilities of the VES-13 and the battery of Comprehensive Geriatric Assessment tools to predict chemotherapy adherence among these patients. * Examine the validity of the VES-13 screening tool to identify increased risk of death from all causes at one year after initial VES-13 screening in these patients. * Examine the validity of the VES-13 screening tool to identify increased risk of functional decline at one year after initial VES-13 screening in these patients. OUTLINE: Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive Geriatric Assessment at baseline and 12 months later. Variables collected include sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor characteristics; therapy; and mortality. Patients are followed for 1 year for chemotherapy adherence and survival.
Conditions
- Breast Cancer
- Cognitive/Functional Effects
- Colorectal Cancer
- Psychosocial Effects of Cancer and Its Treatment
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | compliance monitoring | Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive Geriatric Assessment at baseline and 12 months later. Variables collected include sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor characteristics; therapy; and mortality. |
| DRUG | systemic chemotherapy | Learning about changes over time in older patients' ability to function after receiving chemotherapy for breast or colon cancer |
| OTHER | medical chart review | A limited review of medical records for the sole purpose of evaluating patients for study eligibility will be undertaken by the research team. |
| OTHER | study of socioeconomic and demographic variables | Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive Geriatric Assessment at baseline and 12 months later. Variables collected include sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor characteristics; therapy; and mortality. |
| OTHER | survey administration | Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive Geriatric Assessment at baseline and 12 months later. Variables collected include sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor characteristics; therapy; and mortality. |
| PROCEDURE | cognitive assessment | Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive Geriatric Assessment at baseline and 12 months later. Variables collected include sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor characteristics; therapy; and mortality. |
| PROCEDURE | psychosocial assessment and care | Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive Geriatric Assessment at baseline and 12 months later. Variables collected include sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor characteristics; therapy; and mortality. |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2008-08-25
- Last updated
- 2020-07-27
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00740961. Inclusion in this directory is not an endorsement.